1. Home
  2. VSAT vs NVAX Comparison

VSAT vs NVAX Comparison

Compare VSAT & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSAT
  • NVAX
  • Stock Information
  • Founded
  • VSAT 1986
  • NVAX 1987
  • Country
  • VSAT United States
  • NVAX United States
  • Employees
  • VSAT N/A
  • NVAX N/A
  • Industry
  • VSAT Radio And Television Broadcasting And Communications Equipment
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • VSAT Technology
  • NVAX Health Care
  • Exchange
  • VSAT Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • VSAT 2.4B
  • NVAX 2.0B
  • IPO Year
  • VSAT 1996
  • NVAX 1995
  • Fundamental
  • Price
  • VSAT $10.38
  • NVAX $9.90
  • Analyst Decision
  • VSAT Buy
  • NVAX Buy
  • Analyst Count
  • VSAT 7
  • NVAX 6
  • Target Price
  • VSAT $21.14
  • NVAX $17.83
  • AVG Volume (30 Days)
  • VSAT 1.8M
  • NVAX 7.2M
  • Earning Date
  • VSAT 11-06-2024
  • NVAX 11-07-2024
  • Dividend Yield
  • VSAT N/A
  • NVAX N/A
  • EPS Growth
  • VSAT N/A
  • NVAX N/A
  • EPS
  • VSAT N/A
  • NVAX N/A
  • Revenue
  • VSAT $4,630,427,000.00
  • NVAX $987,667,000.00
  • Revenue This Year
  • VSAT $8.43
  • NVAX N/A
  • Revenue Next Year
  • VSAT $3.27
  • NVAX N/A
  • P/E Ratio
  • VSAT N/A
  • NVAX N/A
  • Revenue Growth
  • VSAT 67.71
  • NVAX N/A
  • 52 Week Low
  • VSAT $9.98
  • NVAX $3.53
  • 52 Week High
  • VSAT $29.11
  • NVAX $23.86
  • Technical
  • Relative Strength Index (RSI)
  • VSAT 36.14
  • NVAX 36.20
  • Support Level
  • VSAT $10.10
  • NVAX $9.52
  • Resistance Level
  • VSAT $10.65
  • NVAX $10.63
  • Average True Range (ATR)
  • VSAT 0.49
  • NVAX 0.57
  • MACD
  • VSAT 0.10
  • NVAX -0.12
  • Stochastic Oscillator
  • VSAT 23.60
  • NVAX 9.97

About VSAT ViaSat Inc.

Viasat Inc provides bandwidth technologies and services in three segments: satellite services: which provides satellite-based high-speed broadband services to consumers, enterprises, and commercial airlines; commercial networks: which develops end-to-end communication and connectivity systems; and government systems: which produces network-centric Internet Protocol-based secure government communication systems. A large majority of the firm's revenue is generated in the United States, it also has its presence in non U.S. countries.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.

Share on Social Networks: